Cullinan Oncology Inc.

NASDAQ: CGEM · Real-Time Price · USD
7.53
-0.23 (-2.96%)
At close: Jun 30, 2025, 3:59 PM
7.53
0.00%
After-hours: Jun 30, 2025, 04:04 PM EDT
-2.96%
Bid 7.51
Market Cap 444.38M
Revenue (ttm) n/a
Net Income (ttm) -178.74M
EPS (ttm) -2.77
PE Ratio (ttm) -2.72
Forward PE -2.6
Analyst Buy
Ask 8.5
Volume 227,584
Avg. Volume (20D) 450,566
Open 7.93
Previous Close 7.76
Day's Range 7.51 - 8.03
52-Week Range 6.85 - 21.01
Beta -0.04

About CGEM

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGEM
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CGEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
5 months ago
+7.66%
Cullinan Therapeutics shares are trading higher af... Unlock content with Pro Subscription
8 months ago
+8.44%
Cullinan Therapeutics shares are trading higher after the FDA cleared the company's IND application for CLN-978.